Real World Safety & Efficacy Experience of Empagliflozin With or Without Metformin in T2DM Patients - EASE Study

Clinical trial NCT05164263 · RECRUITING

Trial details

NCT number: NCT05164263
Sponsor: Getz Pharma
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Type II Diabetes Mellitus Efficacy, Self Safety Issues

Start date: 2021-04-01
Primary completion: 2026-12-31
Enrollment: 2000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.